| Harjeet K Sekhon, MD | |
|
10004 204th Ave E, Ste 2300, Bonney Lake, WA 98391-6539 | |
| (253) 447-3333 | |
| Not Available |
| Full Name | Harjeet K Sekhon |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 15 Years |
| Location | 10004 204th Ave E, Bonney Lake, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518196906 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4301095210 (Michigan) | Secondary |
| 207V00000X | Obstetrics & Gynecology | MD60311871 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Multicare Health System | 7719899897 | 1704 |
News Archive
The Chrysler Group will save itself tens of millions of dollars in health costs through changes it has won from the United Auto Workers union while costing employees and their family up to $1,000 in health care deductibles, according to a deal reported in the Detroit News, which it said is outlined in a March 10 letter to workers, but not publicly announced by either the union or the company.
Embedding clinical images to accompany findings described in a radiology text report enhances radiologists' communication with referring physicians and can improve patient care, according to a study in the March issue of the Journal of the American College of Radiology (www.jacr.org).
Describing PEPFAR as "a targeted approach on a large-scale and with accountability for results," U.S. Global AIDS Coordinator Ambassador Eric Goosby on Tuesday said the program has done more than fight HIV/AIDS, having had a "broader transformational impact ... on the health sector" in many countries, VOA News reports.
Cherwell Laboratories, specialists in products for process validation and environmental monitoring will present their comprehensive product range at the Aseptic Preparation and Dispensing of Medicines (APDM) Course, Leeds Trinity University on 9th & 10th July 2013.
Introgen Therapeutics has announced that it was successful in winning the decision regarding its opposition of European Patent 0 390 323 before the European Patent Office (EPO) in which all claims directed to therapeutic applications of the p53 gene, the active component of Introgen's Advexin molecular therapy, were finally revoked by the EPO's Technical Board of Appeals.
› Verified 5 days ago
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
The Chrysler Group will save itself tens of millions of dollars in health costs through changes it has won from the United Auto Workers union while costing employees and their family up to $1,000 in health care deductibles, according to a deal reported in the Detroit News, which it said is outlined in a March 10 letter to workers, but not publicly announced by either the union or the company.
Embedding clinical images to accompany findings described in a radiology text report enhances radiologists' communication with referring physicians and can improve patient care, according to a study in the March issue of the Journal of the American College of Radiology (www.jacr.org).
Describing PEPFAR as "a targeted approach on a large-scale and with accountability for results," U.S. Global AIDS Coordinator Ambassador Eric Goosby on Tuesday said the program has done more than fight HIV/AIDS, having had a "broader transformational impact ... on the health sector" in many countries, VOA News reports.
Cherwell Laboratories, specialists in products for process validation and environmental monitoring will present their comprehensive product range at the Aseptic Preparation and Dispensing of Medicines (APDM) Course, Leeds Trinity University on 9th & 10th July 2013.
Introgen Therapeutics has announced that it was successful in winning the decision regarding its opposition of European Patent 0 390 323 before the European Patent Office (EPO) in which all claims directed to therapeutic applications of the p53 gene, the active component of Introgen's Advexin molecular therapy, were finally revoked by the EPO's Technical Board of Appeals.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Harjeet K Sekhon, MD 10004 204th Ave E, Ste 2300, Bonney Lake, WA 98391-6539 Ph: (253) 447-3333 | Harjeet K Sekhon, MD 10004 204th Ave E, Ste 2300, Bonney Lake, WA 98391-6539 Ph: (253) 447-3333 |
News Archive
The Chrysler Group will save itself tens of millions of dollars in health costs through changes it has won from the United Auto Workers union while costing employees and their family up to $1,000 in health care deductibles, according to a deal reported in the Detroit News, which it said is outlined in a March 10 letter to workers, but not publicly announced by either the union or the company.
Embedding clinical images to accompany findings described in a radiology text report enhances radiologists' communication with referring physicians and can improve patient care, according to a study in the March issue of the Journal of the American College of Radiology (www.jacr.org).
Describing PEPFAR as "a targeted approach on a large-scale and with accountability for results," U.S. Global AIDS Coordinator Ambassador Eric Goosby on Tuesday said the program has done more than fight HIV/AIDS, having had a "broader transformational impact ... on the health sector" in many countries, VOA News reports.
Cherwell Laboratories, specialists in products for process validation and environmental monitoring will present their comprehensive product range at the Aseptic Preparation and Dispensing of Medicines (APDM) Course, Leeds Trinity University on 9th & 10th July 2013.
Introgen Therapeutics has announced that it was successful in winning the decision regarding its opposition of European Patent 0 390 323 before the European Patent Office (EPO) in which all claims directed to therapeutic applications of the p53 gene, the active component of Introgen's Advexin molecular therapy, were finally revoked by the EPO's Technical Board of Appeals.
› Verified 5 days ago